Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 186 of 5804
-
3D-Printed brain surgery guide may stop dangerous blood clots from returning
Disease control Not yet recruitingChronic subdural hematoma is a collection of blood and fluid on the surface of the brain that is common in older adults. Burr-hole drainage is a standard surgical treatment, but the hematoma may come back in some patients and require another procedure.This study will test whether…
Phase: NA • Sponsor: The Second Hospital of Anhui Medical University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Sugar supplement may calm seizures and stomach troubles in rare genetic disease
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy and safety of AVTX-801 in subjects with SLC35A2-CDG
Phase: PHASE2 • Sponsor: Eva Morava-Kozicz • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New rapid tests aim to speed up ebola and lassa fever diagnosis
Diagnosis Not yet recruitingThis study aim to validate the clinical performances of two newly developed isothermal nucleic acid amplification bioassays modules for EBOV and LASV. Two retrospective studies will be conducted using biobanked patient samples such as plasma samples and buccal swabs already colle…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
Spinal fluid DNA test could personalize brain cancer therapy
Diagnosis Not yet recruitingThis prospective, single-center study will evaluate whether cerebrospinal fluid (CSF) circulating tumor DNA (ctDNA) testing using the Belay Summit assay can improve the clinical management of patients with malignant gliomas or brain metastases from non-small cell lung cancer (NSC…
Phase: NA • Sponsor: Alireza Mansouri • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
AI-Powered ECG could reveal hidden heart recovery after ablation
Knowledge-focused Not yet recruitingBackground Artificial intelligence-enabled electrocardiography (AI-ECG) has emerged as a promising digital biomarker for detecting latent myocardial dysfunction and predicting cardiovascular risk. However, whether serial AI-derived risk estimates reflect myocardial recovery follo…
Sponsor: Ewha Womans University Mokdong Hospital • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Zapping a nerve in the neck may help rewire the brain after traumatic injury
Disease control Not yet recruitingThis study is evaluating whether pairing vagus nerve stimulation (VNS) with structured upper limb rehabilitation therapy can improve arm and hand function in individuals with moderate to severe traumatic brain injury (TBI). Many people who survive a TBI experience long-term weak…
Phase: NA • Sponsor: Stony Brook University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
AI could help spot rare metabolic diseases in newborns
Diagnosis Not yet recruitingThe goal of this clinical trial is to evaluate whether an artificial intelligence (AI)-based interpretation system can accurately diagnose inherited metabolic disorders in newborns undergoing routine screening. The main questions it aims to answer are: What is the sensitivity an…
Phase: NA • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
New study to test anthrax drug in bioterror attack scenario
Disease control Not yet recruitingThis field study is designed such that it may be implemented for any individual with symptomatic inhalational anthrax who has been administered raxibacumab for treatment of anthrax following a mass exposure scenario. This study is designed to describe the clinical effectiveness (…
Phase: PHASE4 • Sponsor: Emergent BioSolutions • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Personalized antibiotic strategy aims to prevent deadly infections after kidney transplant
Disease control Not yet recruitingKidney transplant recipients take medicines that suppress the immune system to prevent rejection of the transplanted kidney. As a result, they have a high risk of infections, especially urinary tract infections (UTIs). Some of these infections can spread to the bloodstream and ca…
Phase: PHASE3 • Sponsor: Susanne Dam Nielsen, MD, DMSc • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Immunotherapy before and after surgery shows promise for lung cancer
Disease control Not yet recruitingThis is a single arm phase II trial enrolling patients with stage II-IIIA non-small cell lung cancer whose disease is deemed amenable for surgical resection and has a PD-L1 level of ≥50%. Patients will receive cemiplimab for 3 cycles followed by surgical resection. The primary en…
Phase: PHASE2 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New hope for pancreatic cancer: experimental drug MRG004A enters final testing phase
Disease control Not yet recruitingThis is a randomized, double-blind, multi-center, phase III study to evaluate the efficacy and safety, pharmacokinetic profile and immunogenicity of MRG004A in patients with advanced pancreatic cancer.
Phase: PHASE3 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a shingles vaccine and diabetes drug save insulin cells?
Disease control Not yet recruitingType 1 diabetes (T1D) is a chronic autoimmune disease characterized by progressive destruction of pancreatic beta cells mediated by autoreactive T lymphocytes, resulting in absolute insulin deficiency. Preservation of residual beta-cell function at the time of diagnosis is a crit…
Phase: PHASE2 • Sponsor: Ministry of Health, Saudi Arabia • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New antibody shot could help babies beat HIV – trial launches
Disease control Not yet recruitingThe goal of this clinical trial is to learn if subcutaneous ePGT121v1-LS added to standard antiretroviral therapy (ART) is safe and helps improve HIV viral suppression in infants living with HIV in South Africa. The study will also learn how the body processes ePGT121v1-LS and wh…
Phase: PHASE1, PHASE2 • Sponsor: Hospital Universitario 12 de Octubre • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain bleed breakthrough? new drug could stop fluid buildup without surgery
Disease control Not yet recruitingHydrocephalus is a serious condition in which fluid builds up inside the brain, often requiring lifelong surgical placement of a shunt to drain excess cerebrospinal fluid (CSF). One of the most common causes of hydrocephalus is bleeding into the brain's fluid spaces after aneurys…
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a One-Week shock wave treatment fix shoulder tears?
Disease control Not yet recruitingThis is a multicenter, randomized controlled clinical study exploring three different extracorporeal shock wave therapy (ESWT) regimens for patients with partial rotator cuff tears, a common cause of chronic shoulder pain and limited movement. Traditional ESWT uses a once-weekly …
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Engineered immune cells take aim at tough blood cancers
Disease control Not yet recruitingThis study is a single-arm, multicenter Investigator-Initiated Trial (IIT) clinical study. The primary objective is to evaluate the safety, pharmacokinetic characteristics, and preliminary efficacy of CAR-T cells in subjects with relapsed/refractory (r/r) CD7-positive hematologic…
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could stem cells help people with spinocerebellar ataxia? new trial aims to find out
Disease control Not yet recruitingThe purpose of this study is verify the safety and efficacy of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Spinocerebellar Ataxia, and in addition, explore the possible mechanisms of UC-MSC therapy in Spinocerebellar Ataxia.
Phase: PHASE2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cord stem cells aim to reboot brain after stroke
Disease control TerminatedThis is a randomized, double-blind study. Human umbilical cord mesenchymal stem cells (hUC-MSC) will be treated on cerebral infarction patients, and evaluates their neurological function of convalescent period.
Phase: PHASE1, PHASE2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Liquid embolization may offer Needle-Free alternative to brain surgery for blood clots
Disease control Not yet recruitingThis is a prospective, randomized, controlled, open-label, blinded endpoint (PROBE) clinical investigation in which patients with non-emergent chronic subdural hematoma (cSDH) requiring treatment will be randomized (1:1) to either initial surgical evacuation (Control Arm) or init…
Phase: NA • Sponsor: Microvention-Terumo, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Stents plus drugs vs. drugs alone: which is better for heart failure?
Disease control Not yet recruitingTo evaluate whether percutaneous coronary intervention (PCI) with contemporary drug-eluting stents (DES) combined with guideline-directed medical therapy (GDMT), compared to GDMT alone, reduces the time to first occurrence of major adverse cardiovascular events (MACE) during a me…
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC